Kuwait Direct-to-consumer Genetic Testing Market Size & Outlook
Related Markets
Kuwait direct-to-consumer genetic testing market highlights
- The Kuwait direct-to-consumer genetic testing market generated a revenue of USD 1.3 million in 2023 and is expected to reach USD 2.9 million by 2030.
- The Kuwait market is expected to grow at a CAGR of 12% from 2024 to 2030.
- In terms of segment, predictive testing was the largest revenue generating test type in 2023.
- Predictive Testing is the most lucrative test type segment registering the fastest growth during the forecast period.
Direct-to-consumer genetic testing market data book summary
| Market revenue in 2023 | USD 1.3 million |
| Market revenue in 2030 | USD 2.9 million |
| Growth rate | 12% (CAGR from 2023 to 2030) |
| Largest segment | Predictive testing |
| Fastest growing segment | Predictive Testing |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Nutrigenomics Testing, Predictive Testing, Carrier Testing, Other Test Types |
| Key market players worldwide | 23andMe Holding Co Class A, Genesis Healthcare Inc Class A, Bureau Veritas SA, Myriad Genetics Inc, Color, Living DNA, Full Genomes, EasyDNA, Ancestry, Family Tree DNA, Nanobiomatters Industries, Milliken & Company, Biocote, Microban International, SteriTouch, Sanitized |
Other key industry trends
- In terms of revenue, Kuwait accounted for 0.1% of the global direct-to-consumer genetic testing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa direct-to-consumer genetic testing market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 11.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Direct-to-Consumer Genetic Testing Market Scope
Direct-to-Consumer Genetic Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Sanitized | View profile | 101-250 | Burgdorf, Bern, Switzerland, Europe | https://www.sanitized.com |
| SteriTouch | View profile | 11-50 | Ebbw Vale, Blaenau Gwent, United Kingdom, Europe | http://www.steritouch.com |
| Microban International | View profile | 51-100 | Huntersville, North Carolina, United States, North America | http://www.microban.com/en-uk |
| Biocote | View profile | 11-50 | Coventry, Coventry, United Kingdom, Europe | https://www.biocote.com |
| Milliken & Company | View profile | 501-1000 | Spartanburg, South Carolina, United States, North America | http://www.milliken.com/en-us/ |
| Nanobiomatters Industries | View profile | 11-50 | Paterna De Rivera, Andalucia, Spain, Europe | http://www.nanobiomatters.com |
| Family Tree DNA | View profile | 11-50 | Houston, Texas, United States, North America | https://www.familytreedna.com/ |
| Ancestry | View profile | - | Melbourne, Victoria, Australia, Oceania | https://www.ancestry.com.au/ |
| EasyDNA | View profile | 11-50 | Grove City, Ohio, United States, North America | https://www.easy-dna.com |
| Full Genomes | View profile | 1-10 | Rockville, Maryland, United States, North America | http://fullgenomes.com |
| Living DNA | View profile | 1-10 | Bridgwater, Somerset, United Kingdom, Europe | https://livingdna.com/ |
| Color | View profile | 501-1000 | Burlingame, California, United States, North America | https://www.color.com |
| Bureau Veritas SA | View profile | 81511 | 40/52 Boulevard du Parc, Immeuble Newtime, Neuilly-sur-Seine, France, 92200 | https://group.bureauveritas.com |
| 23andMe Holding Co Class A | View profile | 816 | 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 | https://www.23andme.com |
| Myriad Genetics Inc | View profile | 2700 | 320 Wakara Way, Salt Lake City, UT, United States, 84108 | https://www.myriad.com |
| Genesis Healthcare Inc Class A | View profile | 44000 | 101 East State Street, Kennett Square, PA, United States, 19348 | http://www.genesishcc.com |
Kuwait direct-to-consumer genetic testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to direct-to-consumer genetic testing market will help companies and investors design strategic landscapes.
Predictive testing was the largest segment with a revenue share of 38.46% in 2023. Horizon Databook has segmented the Kuwait direct-to-consumer genetic testing market based on nutrigenomics testing, predictive testing, carrier testing, other test types covering the revenue growth of each sub-segment from 2018 to 2030.
- Kuwait Direct-to-Consumer Genetic Testing Test Type Outlook (Revenue, USD Million, 2018-2030)
- Nutrigenomics Testing
- Predictive Testing
- Carrier Testing
- Other Test Types
- Kuwait Direct-to-Consumer Genetic Testing Technology Outlook (Revenue, USD Million, 2018-2030)
- Whole Genome Sequencing
- Single Nucleotide Polymorphism Chips
- Targeted Analysis
- Other Technologies
- Kuwait Direct-to-Consumer Genetic Testing Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Online Platform
- OTC
Reasons to subscribe to Kuwait direct-to-consumer genetic testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Kuwait direct-to-consumer genetic testing market databook
-
Our clientele includes a mix of direct-to-consumer genetic testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait direct-to-consumer genetic testing market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait direct-to-consumer genetic testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Kuwait direct to consumer genetic testing market size, by test type, 2018-2030 (US$M)
Kuwait Direct-to-Consumer Genetic Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
